Company intelligence / Profile preview

Trifolio-M

Lahnau, Hesse, Germany

Ownership: Private
Employees: ~40
Development stage: Other

Overview

Trifolio-M is a German biotechnology company specializing in the development and production of high-quality natural products for use in plant protection, animal health, and human health. Founded in 1985, the company is a global leader in the extraction of Azadirachtin from neem seeds, marketed under the brand NeemAzal. Their human health portfolio includes medical devices and biocides for treating head lice and repelling insects. Trifolio-M focuses on sustainable, eco-friendly solutions derived from renewable resources and maintains a strong emphasis on research and development in natural product chemistry.

Therapeutic areas: DermatologyInfectious Diseases
Modalities: Small moleculeNatural product
Industry: Agriculture & AgTech

Partnerships

Justus-Liebig-University Giessen

Beyond the preview

Go deeper on Trifolio-M.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Trifolio-M.

Explore the full profile